Normal Range of Neutrophile to Lymphocyte Ratio in Healthy, Chronic Kidney Disease Stage 4 - 5 and Hemodialysis Participant in a Sub-Saharan African Context
Background: Neutrophile to lymphocyte ratio (NLR) is a well-established marker of inflammation. It has been reported to be high in chronic kidney disease (CKD) and it is described as a prognosis factor in hemodialysis patients. However, limited data are available about the normal range of NLR in healthy adults as well as CKD patients including hemodialysis black Africans in Sub-Saharan countries. We sought to study NLR in healthy and advanced CKD in a single Cameroonian health facility. Methods: Blood samples were obtained from blood donors, CKD stage 4 and non-dialysis stage 5, and hemodialysis patients for more than 6 months. Patients with confounding factors such as positive CRP, infection, and recent use of steroids were excluded. RNL means standard deviations (SDs), and 95% confidence intervals (95% CI) were determined. RNL range was defined as percentiles P2.5 to P97.5. Results: A total of 102 participants were included. Mean age was 40.45 ± 9.97 years and 58.8% were male. Age and sex distribution were similar in the three groups. Leucopenia and neutropenia were common in all the groups. Means NLR was 1.29 ± 0.57 (95% CI 1.08 - 1.49) range between 0.55 to 2.67; 2.31 ± 1.3 (95% CI 1.75 - 2.88) with range between 0.69 to 4.31 and 2.14 ± 0.98 (95% CI 1.85 - 2.44) with range between 0.77 to 4.32 respectively in controls, CKD, and hemodialysis participants. NLR was comparable in CKD and hemodialysis patients (p = 0.99). Compared to controls, NLR was significantly elevated in CKD (p = 0.043) and hemodialysis patients (p < 0.001). Conclusion: Our data suggest that the normal range for NLR in adult nongeriatric healthy and advanced CKD patients including those on chronic hemodialysis may vary between 0.55 to 2.67 and 0.69 to 4.32 respectively.
References
[1]
Kovesdy, C.P. (2022) Epidemiology of Chronic Kidney Disease: An Update 2022. Kidney International Supplements, 12, 7-11. https://doi.org/10.1016/j.kisu.2021.11.003
[2]
Jager, K.J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V. and Zoccali, C. (2019) A Single Number for Advocacy and Communication—Worldwide More than 850 Million Individuals Have Kidney Diseases. Kidney International, 96, 1048-1050. https://doi.org/10.1016/j.kint.2019.07.012
[3]
Meike, Y., Xue, S., Hongli, Q., Yin, P., Lin, Y., Wu, J., Ren, J. and Zheng, Y. (2023) Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019. Nephron, 148, 113-123. https://doi.org/10.1159/000534071
[4]
Rai, N.K., Wang, Z., Drawz, P.E., Connett, J. and Murphy, D.P. (2023) CKD Progression Risk and Subsequent Cause of Death: A Population-Based Cohort Study. Kidney Medicine, 5, Article 100604. https://doi.org/10.1016/j.xkme.2023.100604
[5]
Kadatane, S.P., Satariano, M., Massey, M., Mongan, K. and Raina, R. (2023) The Role of Inflammation in CKD. Cells, 12, Article 1581. https://doi.org/10.3390/cells12121581
[6]
Dominic, S.R., Pecoits-Filho, R. and Kimmel, P.L. (2015) Inflammation in Chronic Kidney Disease. In: Kimmel, P.L. and Rosenberg, M.E., Eds., Chronic Renal Disease, Academic Press, Cambridge, 199-212. https://doi.org/10.1016/B978-0-12-411602-3.00017-2
[7]
Akchurin, O.M. and Kaskel, F. (2015) Update on Inflammation in Chronic Kidney Disease. Blood Purification, 39, 84-92. https://doi.org/10.1159/000368940
[8]
Nano, J., Schöttker, B., Lin, J., Huth, C., Ghanbari, M., Garcia, P.M., Maalmi, H., Karrasch, S., Koenig, W., Rothenbacher, D., Roden, M., Meisinger, C., Peters, A., Brenner, H., Herder, C. and Thorand, B. (2022) Novel Biomarkers of Inflammation, Kidney Function and Chronic Kidney Disease in the General Population. Nephrology Dialysis Transplantation, 37, 1916-1926. https://doi.org/10.1093/ndt/gfab294
[9]
Jalal, D., Sanford, B., Renner, B., Eyck, P.T., Laskowski, J., Cooper, J., Sun, M., Zakharia, Y., Spitz, D., Dokun, A., Attanasio, M., Jones, K. and Thurman, J.M. (2021) Detection of Pro Angiogenic and Inflammatory Biomarkers in Patients with CKD. Scientific Reports, 11, Article No. 8786. https://doi.org/10.1038/s41598-021-87710-0
[10]
Khanijou, V., Zafari, N., Coughlan, M.T., MacIsaac, R. and Ekinci, E.I. (2022) Review of Potential Biomarkers of Inflammation and Kidney Injury in Diabetic Kidney Disease. Diabetes Metabolism Research and Reviews, 38, e3556. https://doi.org/10.1002/dmrr.3556
[11]
Buonacera, A., Stancanelli, B., Colaci, M. and Malatino, L. (2022) Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases. International Journal of Molecular Sciences, 23, Article 3636. https://doi.org/10.3390/ijms23073636
[12]
Lowsby, R., Gomes, C., Jarman, I., Lisboa, P., Nee, P.A., Vardhan, M., Eckersley, T., Saleh, R. and Mills, H. (2015) Neutrophil to Lymphocyte Count Ratio as an Early Indicator of Blood Stream Infection in the Emergency Department. Emergency Medicine Journal, 32, 531-534. https://doi.org/10.1136/emermed-2014-204071
[13]
Niu, D., Huang, Q., Yang, F., Tian, W., Li, C., Ding, L., Fang, H.-C. and Zhao, Y. (2021) Serum Biomarkers to Differentiate Gram-Negative, Gram-Positive and Fungal Infection in Febrile Patients. Journal of Medical Microbiology, 70, Article 001360. https://doi.org/10.1099/jmm.0.001360
[14]
Li,W., Hou, M., Ding, Z., Liu, X., Shao, Y. and Li, X. (2021) Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Stroke: A Systematic Review and Meta-Analysis. Frontiers in Neurology, 12, Article 686983. https://doi.org/10.3389/fneur.2021.686983
[15]
Lee, M.J., Park, S.D., Kwon, S.W., Woo, S.I., Lee, M.D., Shin, S.H., Kim, D.H., Kwan, J. and Park, K.S. (2016) Relation between Neutrophil-to-Lymphocyte Ratio and Index of Microcirculatory Resistance in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. American Journal of Cardiology, 118, 1323-1328. https://doi.org/10.1016/j.amjcard.2016.07.072
[16]
Lee, P., Oen, K., Lim, G., Hartono, J., Muthiah, M., Huang, D., Teo, F., Li, A., Mak, A., Chandran, N., et al. (2021) Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study. Cancers, 13, Article 1308. https://doi.org/10.3390/cancers13061308
[17]
Song, M., Graubard, B.I., Rabkin, C.S. and Engels, E.A. (2021) Neutrophil-to-Lymphocyte Ratio and Mortality in the United States General Population. Scientific Reports, 11, Article No. 464. https://doi.org/10.1038/s41598-020-79431-7
[18]
Forget, P., Khalifa, C., Defour, J.-P., Latinne, D., Van Pel, M.-C. and De Kock, M. (2017) What Is the Normal Value of the Neutrophil-to-Lymphocyte Ratio? BMC Research Notes, 10, Article No. 12. https://doi.org/10.1186/s13104-016-2335-5
[19]
Fest, J., Ruiter, R., Ikram, M.A., Voortman, T., Van Eijck, C.H.J. and Stricker, B.H. (2018) Reference Values for White Blood-Cell-Based Inflammatory Markers in the Rotterdam Study: A Population-Based Prospective Cohort Study. Scientific Reports, 8, Article No. 10566. https://doi.org/10.1038/s41598-018-28646-w
[20]
Karakonstantis, S., Kalemaki, D., Tzagkarakis, E. and Lydakis, C. (2018) Pitfalls in Studies of Eosinopenia and Neutrophil-to-Lymphocyte Count Ratio. Infectious Diseases, 50, 163-174. https://doi.org/10.1080/23744235.2017.1388537
[21]
Uduagbamen, P.K., Oyelese, A.T., AdebolaYusuf, A.O., Thompson, M.U., Alalade, B.A.A. and Ehioghae, O. (2022) Neutrophil Lymphocyte Ratio as an Inflammatory Marker in Chronic Kidney Disease: Determinants and Correlates. Open Journal of Nephrology, 12, 23-35. https://doi.org/10.4236/ojneph.2022.121003
[22]
Yoshitomi, R., Nakayama, M., Sakoh, T., Fukui, A., Katafuchi, E., Seki, M., Tsuda, S., Nakano, T., Tsuruya, K. and Kitazono, T. (2019) High Neutrophil/Lymphocyte Ratio Is Associated with Poor Renal Outcomes in Japanese Patients with Chronic Kidney Disease. Renal Failure, 41, 238-243. https://doi.org/10.4236/ojneph.2022.121003
[23]
Yuan, Q., Wang, J., Peng, Z., et al. (2019) Neutrophil-to-Lymphocyte Ratio and Incident End-Stage Renal Disease in Chinese Patients with Chronic Kidney Disease: Results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). Journal of Translational Medicine, 17, Article No. 86. https://doi.org/10.1186/s12967-019-1808-4
[24]
Azab, B., Camacho-Rivera, M. and Taioli, E. (2014) Average Values and Racial Differences of Neutrophil Lymphocyte Ratio among a Nationally Representative Sample of United States Subjects. PLOS ONE, 9, e112361. https://doi.org/10.1371/journal.pone.0112361
[25]
Bain, B.J. (1996) Ethnic and Sex Differences in the Total and Differential White Cell Count and Platelet Count. Journal of Clinical Pathology, 49, 664-666. https://doi.org/10.1136/jcp.49.8.664
[26]
Mohamed, M.A., Mahgoub, N.M., Osman, N.M., Saeed, S.S., Elmubark, T.Y. and Abass, A.E. (2017) Reference Value of Neutrophil-Lymphocyte Ratio in Healthy Sudanese in Khartoum. Scholars Journal of Applied Medical Sciences, 5, 1915-1919.
[27]
Zhang, J., Lu, X., Wang, S. and L,i H. (2021) High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis. BioMed Research International, 2021, Article ID: 9958081. https://doi.org/10.1155/2021/9958081
[28]
Liao, J., Wei, D., Sun, C., Yang, Y., Wei, Y. and Liu, X. (2022) Prognostic Value of the Combination of Neutro-phil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on Mortality in Patients on Maintenance Hemodialysis. BMC Nephrology, 23, Article No. 393. https://doi.org/10.1186/s12882-022-03020-1
[29]
Gobina, R., Kaze, F., Ngo Makang, C., Sylvia Santerre, V., Tsiazok, M., Njonkam, L., Soh, D., Mukwelle, K., Ndjong, E., Maimouna, M., Nono, A., Fouda, H., Tayou, C. and Ashuntantang, G. (2020) The Neutrophil to Lymphocyte Ratio as a Marker of Inflammation in Patients on Maintenance Hemodialysis in Yaounde. Kidney International Reports, 5, S289. https://doi.org/10.1016/j.ekir.2020.02.751
[30]
Zahorec, R. (2021) Neutrophil-to-Lymphocyte Ratio, Past, Present and Future Perspectives. Bratislava Medical Journal, 122, 474-488. https://doi.org/10.4149/BLL_2021_078
[31]
Gurol, G., Ihsan, H.C., Huseyin, A.T., Ali, R.A., Ozbek, A. and Koroglu, M. (2015) Are There Standardized Cutoff Values for Neutrophil-Lymphocyte Ratios in Bacteremia or Sepsis? Journal of Microbiology and Biotechnology, 25, 521-525. https://doi.org/10.4014/jmb.1408.08060
[32]
Fouda, H.D., Mahamat, M., Nzana, V., Mbatchou, B.H., Barla, E., Kaze, F.F., Ashuntantang, G., Luma, N.H. and Halle, M.P. (2021) La Mortalité en Hémodialyse Chronique avant et pendant la Pandémie à COVID-19 à l’Hôpital Général de Douala. Health Sciences and Disease, 22, 61-64. http://www.hsd-fmsb.org/index.php/hsd/article/view/2953/2684
[33]
Li, P., Xia, C., Liu, P., et al. (2020) Neutrophil-to-Lymphocyte Ratio and Plate-let-to-Lymphocyte Ratio in Evaluation of Inflammation in Non-Dialysis Patients with End-Stage Renal Disease (ESRD). BMC Nephrology, 21, Article No. 511. https://doi.org/10.1186/s12882-020-02174-0
